404 related articles for article (PubMed ID: 8612509)
1. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol.
Ignar-Trowbridge DM; Pimentel M; Parker MG; McLachlan JA; Korach KS
Endocrinology; 1996 May; 137(5):1735-44. PubMed ID: 8612509
[TBL] [Abstract][Full Text] [Related]
2. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element.
Ignar-Trowbridge DM; Teng CT; Ross KA; Parker MG; Korach KS; McLachlan JA
Mol Endocrinol; 1993 Aug; 7(8):992-8. PubMed ID: 8232319
[TBL] [Abstract][Full Text] [Related]
3. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.
Cho H; Katzenellenbogen BS
Mol Endocrinol; 1993 Mar; 7(3):441-52. PubMed ID: 7683375
[TBL] [Abstract][Full Text] [Related]
4. Cross talk between peptide growth factor and estrogen receptor signaling systems.
Ignar-Trowbridge DM; Pimentel M; Teng CT; Korach KS; McLachlan JA
Environ Health Perspect; 1995 Oct; 103 Suppl 7(Suppl 7):35-8. PubMed ID: 8593872
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor but not insulin-like growth factor-I potentiates adenosine 3',5'-monophosphate-mediated chorionic gonadotropin secretion by cultured human choriocarcinoma cells.
Ritvos O; Jalkanen J; Pekonen F; Stenman UH; Ranta T
Endocrinology; 1988 Aug; 123(2):859-65. PubMed ID: 2840269
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I.
Aronica SM; Katzenellenbogen BS
Mol Endocrinol; 1993 Jun; 7(6):743-52. PubMed ID: 7689695
[TBL] [Abstract][Full Text] [Related]
7. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells.
Lowe WL; Fu R; Banko M
Endocrinology; 1997 Jun; 138(6):2219-26. PubMed ID: 9165004
[TBL] [Abstract][Full Text] [Related]
8. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines.
Koga M; Musgrove EA; Sutherland RL
Cancer Res; 1990 Aug; 50(16):4849-55. PubMed ID: 2379149
[TBL] [Abstract][Full Text] [Related]
10. Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells.
Chalbos D; Philips A; Galtier F; Rochefort H
Endocrinology; 1993 Aug; 133(2):571-6. PubMed ID: 8344199
[TBL] [Abstract][Full Text] [Related]
11. Distinct adenosine 3',5'-monophosphate and phorbol ester-responsive signal transduction pathways converge at the level of transcriptional activation by the interactions of DNA-binding proteins.
Hoeffler JP; Deutsch PJ; Lin J; Habener JF
Mol Endocrinol; 1989 May; 3(5):868-80. PubMed ID: 2547158
[TBL] [Abstract][Full Text] [Related]
12. Involvement of protein kinase-C in the mitogenic effect of insulin-like growth factor-I on rat astrocytes.
Tranque PA; Calle R; Naftolin F; Robbins R
Endocrinology; 1992 Oct; 131(4):1948-54. PubMed ID: 1396338
[TBL] [Abstract][Full Text] [Related]
13. Growth factors interact with estradiol and gonadotropins in the regulation of ovarian cancer cell growth and growth factor receptors.
Wimalasena J; Meehan D; Dostal R; Foster JS; Cameron M; Smith M
Oncol Res; 1993; 5(8):325-37. PubMed ID: 8012064
[TBL] [Abstract][Full Text] [Related]
14. Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.
Lee AV; Weng CN; Jackson JG; Yee D
J Endocrinol; 1997 Jan; 152(1):39-47. PubMed ID: 9014838
[TBL] [Abstract][Full Text] [Related]
15. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
Boerner JL; Gibson MA; Fox EM; Posner ED; Parsons SJ; Silva CM; Shupnik MA
Mol Endocrinol; 2005 Nov; 19(11):2660-70. PubMed ID: 15976008
[TBL] [Abstract][Full Text] [Related]
16. Regulation of TGF-alpha expression in human keratinocytes: PKC-dependent and -independent pathways.
Klein SB; Fisher GJ; Jensen TC; Mendelsohn J; Voorhees JJ; Elder JT
J Cell Physiol; 1992 May; 151(2):326-36. PubMed ID: 1572907
[TBL] [Abstract][Full Text] [Related]
17. Regulation of proliferation and apoptosis by epidermal growth factor and protein kinase C in human ovarian surface epithelial cells.
McClellan M; Kievit P; Auersperg N; Rodland K
Exp Cell Res; 1999 Feb; 246(2):471-9. PubMed ID: 9925763
[TBL] [Abstract][Full Text] [Related]
18. Suppression of ligand-dependent estrogen receptor activity by bone-resorbing cytokines in human osteoblasts.
Bodine PV; Harris HA; Komm BS
Endocrinology; 1999 Jun; 140(6):2439-51. PubMed ID: 10342828
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
[TBL] [Abstract][Full Text] [Related]
20. Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk.
Klotz DM; Hewitt SC; Ciana P; Raviscioni M; Lindzey JK; Foley J; Maggi A; DiAugustine RP; Korach KS
J Biol Chem; 2002 Mar; 277(10):8531-7. PubMed ID: 11751931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
